It’s the second most common type of cancer among men and affects 1 in every 8 men in the United States. September is Prostate Cancer Awareness Month, and the American Cancer Society says this type of ...

Routine prostate cancer screenings save lives, yet some men still avoid them. However, making the process more streamlined increases the likelihood that men will get the tests they need to catch ...

Credit: Thinkstock By 5 years, 92% of men recovered pad-free continence, and 87% had preserved erectile function sufficient for penetration. MRI-guided whole-gland transurethral ultrasound ablation ...

New Publication Shows PROSTOX™ ultra Test Delivers Significant Health System Cost Savings and Quality-of-Life Gains for Prostate Cancer Patients Undergoing Radiation Therapy MiraDx, a molecular ...

Virginia Commonwealth University's (VCU) Massey Comprehensive Cancer Center in Richmond is the first site in Virginia to offer a new non-surgical robotic ultrasound procedure for prostate cancer, ...

Duke University Medical Center is one of 12 centers in the country testing the safety and effectiveness of a minimally invasive procedure called High Intensity Focused Ultrasound (HIFU). Since 79-year ...

Biopsies guided by high resolution ultrasound are as effective as those using MRI in diagnosing prostate cancer, an international clinical trial has shown. The technology, called micro-ultrasound, is ...

The 2 groups--those receiving ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy--had similar overall survival, which was 81% and 79%, respectively, at 10 years.

Koelis, SAS ("Koelis" or the "Company", a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer interventions, recently announced that the Centers for Medicare & Medicaid ...

Brachytherapy and proton therapy are radiation therapies, while HIFU and TULSA are focal therapies with distinct mechanisms. Medicare typically covers HIFU but not TULSA, with potential future ...

UHF noninferior to conventionally fractionated radiotherapy for men with intermediate- to high-risk localized disease. (HealthDay News) — Ultra-hypofractionated (UHF) radiotherapy delivered over two ...